Lipocine Inc. Files 8-K with Office and Contact Details
Ticker: LPCN · Form: 8-K · Filed: Dec 13, 2024 · CIK: 1535955
| Field | Detail |
|---|---|
| Company | Lipocine Inc. (LPCN) |
| Form Type | 8-K |
| Filed Date | Dec 13, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, address-update
Related Tickers: LPCN
TL;DR
Lipocine Inc. (LPCN) filed an 8-K updating its address and contact info. Nothing major, just housekeeping.
AI Summary
Lipocine Inc. filed an 8-K on December 13, 2024, reporting an event. The filing details the company's principal executive offices located at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah, 84108. The company's telephone number is (801) 994-7383. This report is filed under the Securities Exchange Act of 1934.
Why It Matters
This filing provides essential corporate information and contact details for Lipocine Inc., which is important for investors and stakeholders to stay informed about the company's operational base.
Risk Assessment
Risk Level: low — The filing is routine and primarily provides updated corporate contact and address information, with no indication of significant financial or operational changes.
Key Players & Entities
- Lipocine Inc. (company) — Registrant
- 675 Arapeen Drive, Suite 202, Salt Lake City, Utah, 84108 (location) — Principal executive offices
- (801) 994-7383 (phone_number) — Registrant's telephone number
- December 13, 2024 (date) — Date of Earliest Event Reported
FAQ
What is the primary purpose of this 8-K filing for Lipocine Inc.?
The primary purpose of this 8-K filing is to report current information as required by the Securities Exchange Act of 1934, specifically detailing the company's principal executive offices and contact information.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on December 13, 2024.
What is the exact address of Lipocine Inc.'s principal executive offices?
The exact address of Lipocine Inc.'s principal executive offices is 675 Arapeen Drive, Suite 202, Salt Lake City, Utah, 84108.
What is Lipocine Inc.'s telephone number?
Lipocine Inc.'s telephone number, including the area code, is (801) 994-7383.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
Filing Stats: 412 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2024-12-13 06:06:57
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share LPCN The NASDAQ Stock Mar
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 43KB
- form8-k_001.jpg (GRAPHIC) — 6KB
- ex99-1_001.jpg (GRAPHIC) — 1401KB
- ex99-1_002.jpg (GRAPHIC) — 2513KB
- ex99-1_003.jpg (GRAPHIC) — 1857KB
- ex99-1_004.jpg (GRAPHIC) — 1958KB
- ex99-1_005.jpg (GRAPHIC) — 1356KB
- ex99-1_006.jpg (GRAPHIC) — 1820KB
- ex99-1_007.jpg (GRAPHIC) — 2020KB
- ex99-1_008.jpg (GRAPHIC) — 1893KB
- ex99-1_009.jpg (GRAPHIC) — 1948KB
- ex99-1_010.jpg (GRAPHIC) — 1984KB
- ex99-1_011.jpg (GRAPHIC) — 1966KB
- ex99-1_012.jpg (GRAPHIC) — 1541KB
- ex99-1_013.jpg (GRAPHIC) — 1528KB
- ex99-1_014.jpg (GRAPHIC) — 1322KB
- ex99-1_015.jpg (GRAPHIC) — 1843KB
- ex99-1_016.jpg (GRAPHIC) — 2342KB
- ex99-1_017.jpg (GRAPHIC) — 1636KB
- ex99-1_018.jpg (GRAPHIC) — 1712KB
- ex99-1_019.jpg (GRAPHIC) — 2119KB
- ex99-1_020.jpg (GRAPHIC) — 1985KB
- ex99-1_021.jpg (GRAPHIC) — 1983KB
- ex99-1_022.jpg (GRAPHIC) — 1492KB
- ex99-1_023.jpg (GRAPHIC) — 1672KB
- ex99-1_024.jpg (GRAPHIC) — 1470KB
- ex99-1_025.jpg (GRAPHIC) — 1390KB
- ex99-1_026.jpg (GRAPHIC) — 2011KB
- ex99-1_027.jpg (GRAPHIC) — 1961KB
- ex99-1_028.jpg (GRAPHIC) — 2107KB
- ex99-1_029.jpg (GRAPHIC) — 1396KB
- ex99-1_030.jpg (GRAPHIC) — 2622KB
- ex99-1_031.jpg (GRAPHIC) — 1705KB
- ex99-1_032.jpg (GRAPHIC) — 1946KB
- ex99-1_033.jpg (GRAPHIC) — 1425KB
- ex99-1_034.jpg (GRAPHIC) — 2095KB
- ex99-1_035.jpg (GRAPHIC) — 1846KB
- ex99-1_036.jpg (GRAPHIC) — 2140KB
- ex99-1_037.jpg (GRAPHIC) — 1330KB
- ex99-1_038.jpg (GRAPHIC) — 1897KB
- ex99-1_039.jpg (GRAPHIC) — 1596KB
- ex99-1_040.jpg (GRAPHIC) — 1332KB
- ex99-1_041.jpg (GRAPHIC) — 1648KB
- ex99-1_042.jpg (GRAPHIC) — 1105KB
- ex99-1_043.jpg (GRAPHIC) — 1543KB
- ex99-1_044.jpg (GRAPHIC) — 1867KB
- ex99-1_045.jpg (GRAPHIC) — 1853KB
- 0001493152-24-049874.txt ( ) — 110321KB
- lpcn-20241213.xsd (EX-101.SCH) — 3KB
- lpcn-20241213_lab.xml (EX-101.LAB) — 33KB
- lpcn-20241213_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIPOCINE INC. Date: December 13, 2024 By: /s/ Mahesh V. Patel Mahesh V. Patel President and Chief Executive Officer